In this podcast, Ryan Maddox, PhD, from the CDC, answers our questions about his team's latest study on the incidence of prion disease in the United States from 2003 to 2015, as well as discusses his other research in this area. More at: www.consultant360.com/infectious-diseases.

In this podcast, Thomas Holland, MD, from Rush University, answers our questions about his team's latest research on the effect of flavonols on the risk for Alzheimer dementia, as well as his other research in this area. More at: www.consultant360.com/neurology

In this podcast, Peter Libby, MD, gives an overview of clonal hematopoiesis of indeterminate potential, how it relates to cardiovascular medicine, and why it should be on your radar. More at: www.consultant360.com/cardiology

In this podcast, Rachana Kulkarni, MD, from the American Heart Association, answers our questions about managing CVD in women who are pregnant, the challenges she has experienced when managing these patients, and more. More at: www.consultant360.com/cardiology

In this podcast, Robert S. Rosenson, MD, from Mount Sinai Heart at the Icahn School of Medicine at Mount Sinai, discusses recent research about secondary prevention of atherosclerotic cardiovascular disease (ASCVD) and the implications of the research for clinical practice. More at: www.consultant360.com/cardiology

In this podcast, Benjamin H. Freed, MD, answered our questions about his latest research on diffuse right ventricular fibrosis among patients with pulmonary arterial hypertension and comorbid heart failure with preserved ejection fraction. More at: www.consultant360.com/pulmonology

In this podcast, Marc Ghany, MD, MHSc, discusses the recent publication of "Hepatitis C Guidance 2019 Update: AASLD‐IDSA Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection." He was a cochair of the writing committee for this guidance. More at: www.consultant360.com/infectious-diseases or www.consultant360.com/gastroenterology

In this podcast, Brooke Nichols, PhD, answers our questions about her team's novel and pragmatic metric to evaluate and compare pre-exposure prophylaxis (PrEP) program effectiveness using routine implementation data. More at: www.consultant360.com/infectious-diseases.

In this podcast, Julian Bailes, MD, discusses traumatic brain injury, including mild traumatic brain injury (concussion) as well as chronic traumatic encephalopathy. More at: www.consultant360.com/neurology.

In this podcast, Linda Beer, PhD, from the Centers for Disease Control and Prevention, talks about her team's latest analysis of US surveillance data of adults with HIV infection that examined the financial barriers to antiretroviral therapy adherence. More at: www.consultant360.com/infectious-diseases.